Vertex stock price target lowered to $15 by TD Cowen on valuation

TD Cowen lowered its price target for Vertex Inc. (VERX) to $15.00 from $16.00, maintaining a Buy rating. The firm expects Q3 results above consensus and raised fiscal 2026 guidance. Vertex shares have underperformed, down 35% YTD, but are potentially undervalued. Q2 results beat EPS and revenue estimates, but cloud growth guidance was lowered. Analysts have mixed views on the stock's outlook.

Original reporting
Published Oct 13, 2026, 10:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VERX
Bearish
high confidence
Mentioned
$VERX
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$VERXBearishLow
01

Why it matters

Analyst downgrades reflect concerns over cloud guidance, but the company retains strong gross margins and ARR growth potential.

02

Market read

Analyst target revisions signal short‑term downside risk for VERX, though longer‑term growth drivers remain.

03

What to watch

Potential upside from upcoming AI product set expansion and improved ARR growth could offset short‑term guidance miss.

Relevance 4/10Novelty 3/10Timing: post‑market reaction

Background

Vertex reported Q2 revenue of $204 M, beating estimates, but missed cloud growth expectations, prompting analyst target revisions.

Company-level read

Ticker impact

$VERXBearishHigh confidence
Context

TD Cowen lowered its price target to $15 and DA Davidson cut its target to $12 after Vertex's Q2 results and cloud guidance miss.

Expected impact

likely modest price decline as investors price in lower guidance and target reductions

Evidence & confidence

Multiple analysts reduced targets on the same day, indicating consensus on weaker outlook.

Market effects

AI chip and cloud software sector faces heightened scrutiny as analysts question growth prospects.

U.S. tech stocks may see slight pullback amid broader AI‑related valuation concerns.

Limited; impact confined to Vertex and peers in the AI‑software niche.

Counterpoint

Target cuts may be overdone if Vertex can accelerate e‑invoicing growth and stabilize cloud conversion rates.

Key entities

  • TD Cowen

    Maintains Buy rating but lowers price target to $15.

  • DA Davidson

    Cuts price target to $12 after cloud guidance miss.

  • BMO Capital

    Raises price target to $15 citing e‑invoicing growth.

Related articles

$VERXMed

Needham raises Vertex stock price target on strong Q3 results

Needham raised its price target on Vertex Inc. (VERX) to $30 from $20, citing strong Q3 results. Revenue beat estimates by 1.7%, and adjusted EBITDA surpassed forecasts by 15%. Q4 guidance was mixed, with revenue lowered but EBITDA raised. DA Davidson also raised its target to $16, noting cloud growth. Vertex's Q3 earnings exceeded expectations, with adjusted EPS of $0.26 and revenue of $213.3M. The company raised its full-year outlook, citing stronger margins and e-invoicing demand.

$VERXMed

DA Davidson raises Vertex stock price target on cloud growth

DA Davidson raised its price target on Vertex Inc. (NASDAQ:VERX) to $16 from $12, citing strong Q3 2026 earnings and accelerated cloud growth. The company increased its fiscal 2026 cloud growth guidance to 19%. Vertex's stock is trading at $15.92 with a P/E ratio of 735, and it has gained 7% over the past week. The company reported adjusted earnings of $0.26 per share, beating estimates, and revenue of $213.3 million, also exceeding forecasts.

$VERXMed

Vertex Inc (VERX) Q3 2026 Earnings Call Highlights: Revenue Tops Guidance as Cloud

Vertex Inc (VERX) reported Q3 2026 revenue above guidance, but faces challenges including a $1M revenue impact from a lost OEM and potential deceleration in e-invoicing growth. Q4 adjusted EBITDA margins are expected to decline to $58-60M due to marketing expenses. CEO Christopher Young highlighted strong e-invoicing growth and expansion opportunities, while CFO John Schwab noted durable margin improvements and targeted reinvestments.

$VERXMed

What Vertex (VERX) Said on Its Q3 Earnings Call

Vertex (VERX) raised its full-year revenue forecast to $828.9M-$830.9M and adjusted EBITDA to $217.9M-$219.9M. Q4 revenue is expected at $215M-$217M. E-invoicing revenue grew over 100% YoY, driven by France's mandate and Brinta's contribution. Vertex introduced AI-powered tax solutions and repurchased $27M in shares Q3.